Scientific Programme
 
Scientific programmeSearch Abstract
 
Session
 
EP08B - What is the current state of the science on the fate, exposure and effects of pharmaceuticals in the environment?
Date: Tuesday, 22 May 2012
Time:10:50-12:50
Room:ECC Room 1
 
10:50-11:10
Does the environmental risk assessment within the marketing authorization procedure ensure the environmental safety of Human Pharmaceuticals? EP08B-1
Rönnefahrt, I.;   Adler, N.;   Hein, A.;   Maack, G. (Dessau, Germany)
 
11:10-11:30
Prioritizing cytotoxic drugs present in aquatic systems and their occurrence in the environment EP08B-2
Booker, V.L.;   Halsall, C.;   Llewellyn, N.;   Johnson, A.;   Jürgens, M.D. (Lancaster, United Kingdom)
 
11:30-11:50
Ecotoxicity from antimicrobials and analgesics during an influenza pandemic EP08B-3
Schmitt, H.;   Singer, A.C.;   Colizza, V. (Utrecht, Nederland)
 
11:50-12:10
Emission of human antibiotics and antineoplastics into the environment: identification of high risk exposure scenarios in Europe EP08B-4
Oldenkamp, R.;   Huijbregts, M.A.J.;   Hollander, A.;   Ragas, A.M.J. (Nijmegen, Nederland)
 
12:10-12:30
Antibiotic-induced change of bacterial communities associated with the copepod Nitocra spinipes EP08B-5
Gorokhova, E.;   Edlund, A.;   Ek, K.;   Breitholtz, M. (Stockholm, Sweden)
 
12:30-12:50
Ciprofloxacin toxicity in five marine species EP08B-6
Smith, A.J.;   Askem, C.;   Fisher, T.;   Hutchinson, T.;   Balaam, J. (Lowestoft, United Kingdom)